Page 14 - Accruing News Today : Breaking News, Live Updates & Top Stories | Vimarsana

New data is accruing. it's hard to give advisers a fixed snapshot of what the efficacy is of the clinical trial of the data set. if they wait longer if they administer the third dose in that clinical trial. they'll have perhaps a better measure of a effectiveness from this trial. but also have a settle data set. a firm picture of what level of effectiveness the vaccine is delivering. >> the fda vaccine advisory committee delayed a meeting which was set for tuesday. meantime across the united states. a growing number of states moving to end mask mandates even though the guidance from the cdc ha...

Better sense of why the fda decided to delay moving forward with a covid vaccine authorization for children under 5 years old. dr. scott gottlieb, former fda commissioner and current board member for pfizer says the decision was not because of any safety issues regarding the shot, but instead, about defining its level of efficacy amid an ongoing trial involving a third vaccine dose. >> given the fact that that is changing, that's evolving, new data is accruing, it's hard for the fda to give its advisers a fixed snapshot of what the absolute efficacy of this clinical trial of the data set. so i...

Authorization for the vaccine for children, and it's about finding the level of efficacy amid a ongoing trial involving a third dose of the vaccine. >> given the fact that that is changing, that's evolving, new data is accruing. it's hard for the fda to give its advisers a fixed snap shop what of efficacy, so if they wait longer and administer the third dose in that clinical trial, they will have a better measure of the effectiveness, but they will have a very firm picture of what level of effectiveness the vaccine is delivering. >> across the united states, hundreds of thousands of vaccine do...

Nation," he's also a pfizer board member. take a listen. >> given the fact that's changing, that's evolving. new data is accruing, it's hard for fda to give a fixed snapshot of what the efficacy of this clinical data set so if they wait a little longer, if they administer the third dose in that clinical trial, they're not only going to have perhaps a better measure of effectiveness from this trial, but they'll also have a data set, a firm picture of what level of effectiveness the vaccine is delivering. >> and that wait, we might have to wait until april. pfizer said it could have data on its ...

They're trying not to let russia get too isolated, but i think even the chinese understand it is not in their interests to blow up the international order and to blow up the international economy, especially when letting putin twist in the wind as he is doing now is actually to china's advantage. no matter how this ends, excuse me, this is going to end with a much weaker russia that's going to be somewhat dependent on china. putin has made one of the greatest strategic blunders of the past 50 or 60 years, and that's to the advantage of china. so i don't see where china, unless i'm misreading x...